Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer - Wikidata - awgldk - TriplyDB

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer

http://www.wikidata.org/entity/Q37578728

about

CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.New trends in molecular and cellular biomarker discovery for colorectal cancer Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives Familial colorectal cancer screening: When and what to do?Tumour biomarkers: homeostasis as a novel prognostic indicator Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer The Genome Conformation As an Integrator of Multi-Omic Data: The Example of Damage Spreading in Cancer Viral oncolysis - can insights from measles be transferred to canine distemper virus?Clinical application of genetics in management of colorectal cancer.Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.Association of Wilms' tumor 1 gene single-nucleotide polymorphism rs16754 with colorectal cancer The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription Colorectal cancer carcinogenesis: a review of mechanisms Clinicopathologic Significance of Extranodal Tumor Extension in Colorectal Adenocarcinoma with Regional Lymph Node Metastasis.Impact of Microsatellite Instability in Signet-Ring Cell and Mucinous Components in Patients With Colorectal Carcinoma.Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.Colorectal cancer and the KIR genes in the human genome: A meta-analysis.The role of epigenetics in colorectal cancer.Early detection of colorectal cancer: from conventional methods to novel biomarkers.Genetic markers of recurrence in colorectal cancer.Diagnostic and prognostic epigenetic biomarkers in cancer.The role of epigenetics in genetic and environmental epidemiology.Epigenetic Biomarkers for the Early Detection of Gastrointestinal Cancer.Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications.High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression.Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects.Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.Case-control study of candidate gene methylation and adenomatous polyp formation.Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery.Methylation of the UNC5C gene and its protein expression in colorectal cancer.The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.The role of pparγ and autophagy in ros production, lipid droplets biogenesis and its involvement with colorectal cancer cells modulation.Current and future biomarkers in colorectal cancer.The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer.MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.

P2860

Q24306296-63E94AAD-30E3-4ED7-9706-380E363B88AA Q26739049-B3493868-A476-4FD8-BC52-1A8F7AF5D6DD Q26751035-AD36B09C-B307-4342-87C4-08CD42586D24 Q26781466-B69030FB-E531-40B2-AB48-941B236A577A Q26799754-76E306C5-F72D-409F-8E14-F00E2D927B60 Q28069898-7179DCAD-1EA4-4412-86AB-5AF1E261FE22 Q28080176-FE42B36F-CEA6-40A9-BE51-8272188ACC50 Q31145202-BE52E027-896A-44B7-937B-A14EBEE5BEB7 Q33820717-9D0154FB-0282-4376-A57F-93CCDAA90E2D Q34378719-D773AD76-B711-492D-8DEC-8160176A368F Q36220792-2FEECF23-A50E-4B68-B6F6-21CC7243460A Q36280804-16F675F4-42B6-42A5-ABB7-2D0178EF73A1 Q36334597-C2D0C06A-3E8D-408F-A2AD-A6EEC9C959EE Q36707302-5A7BDC3E-0B83-417D-9802-0FA0EDC9943A Q36849645-DB8BFC18-52FC-49AD-BFAD-85F0C56641C2 Q36861037-8CD6A600-D6B4-49BA-992F-A24E9BE6C96E Q36896752-E0DB516E-9B0C-4D4E-B416-46D6919FE8A2 Q37056978-00086AB5-BA39-418E-8673-66E6F3E6FEAD Q37399066-ABBFE026-C05A-4F4E-8DF3-B150F6BA60AA Q38215665-175D650E-B2C9-4891-B107-B5FFB18967C7 Q38357717-E426857D-DF06-4935-9387-236CD64E6EFF Q38565301-0C865A08-54F4-4110-B92E-4CC5B2441789 Q38610743-A409F2EF-51B3-4EA5-B840-4A5964D07B2D Q38617120-C3949F20-8341-46F8-9CD5-93F43A388B72 Q38671092-0D64D618-ACB6-4DE9-8914-531070DA8C8C Q38722180-1CBC9593-ED75-4543-AA90-EDF0733D4E0A Q38732716-8F84E94A-5249-4B8F-BF4D-6D5DFB5AEC55 Q38753052-38A52FCC-F476-4481-B790-4F1DFAF6532F Q38809824-1ED43564-F523-4307-840E-7F6A7D8D4095 Q38854906-4F7ACB84-417F-4AA8-AD52-62350626D286 Q39165476-CFA25FDF-66E0-4A61-90E3-4CA07B0052A4 Q39258008-D24B1ACA-6187-46B8-9F3E-FC011E1688B5 Q39968854-1CB749A6-9219-4738-96F5-3A698C1DB2B9 Q40257517-70746D91-5686-4EF3-9830-59571D29F95E Q41361628-D7589083-9738-44E6-8A10-6D22F050A779 Q41505555-B17A8C20-375F-480E-8F29-923435856F5D Q41712337-6ABEE56B-4644-43DB-A7B1-BBD0820439E0 Q43492228-CE3FD821-D9DF-4C16-B134-661034C533A4 Q46123774-1F01D210-067A-4F64-9B0F-C840C763F9C2 Q49211101-EFA3506C-7D6F-4913-BB19-5CAA3D81C3B0

P2860

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer

http://www.wikidata.org/entity/Q37578728

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic and epigenetic biomark ...... treatment of colorectal cancer

@en

Genetic and epigenetic biomark ...... reatment of colorectal cancer.

@nl

type

label

Genetic and epigenetic biomark ...... treatment of colorectal cancer

@en

Genetic and epigenetic biomark ...... reatment of colorectal cancer.

@nl

prefLabel

Genetic and epigenetic biomark ...... treatment of colorectal cancer

@en

Genetic and epigenetic biomark ...... reatment of colorectal cancer.

@nl

P1433

Q37578728-F9D3AF00-9DBB-4ED2-9E5A-0548B74FA2EF

P1476

Q37578728-43C13E3F-9796-4C60-B42A-E2ACE746B971

P2093

Q37578728-45690E42-B48D-463E-AB9E-A26577A0C7E8

Q37578728-732A84F1-A3AF-4594-BD89-B4B4A1EFE52A

Q37578728-B744A9F4-A19B-460F-AB04-31D379985CBC

Q37578728-DD5DBCCB-B1B9-4C35-87CF-7817D572BC77

P2860

Q37578728-0026BE7C-521F-4E94-B7DB-8AB9938CCA90

Q37578728-01674FDD-96DF-4DE2-9425-0849EA38A019

Q37578728-0461AC97-472A-4A8A-9AC9-56D7FE7ED0BC

Q37578728-0688846D-5B25-4007-B114-4C8EEFA6EE5E

Q37578728-079BE96A-DF43-4714-B74A-322CADC3EAAC

Q37578728-091A6AE7-816A-47B5-B2CD-334E1C122D40

Q37578728-098D0499-1646-4972-BD87-8F07A0FD45F7

Q37578728-0CD19FBD-69BF-41A3-8F5F-12D31DF3365E

Q37578728-17E71DE4-7E32-43FF-9C67-CB99CFEC36AD

Q37578728-1B626612-4BD1-4B51-9FA0-2AAD5F4D2E71

P304

Q37578728-3E8838BE-9F81-4964-BF77-ED22BFD0F928

P31

Q37578728-80E7A55C-5B36-472C-B120-D1B8DE808EB6

P356

Q37578728-1E31B5AD-28C0-4A03-AC7D-64FCA8C4E401

P407

Q37578728-8E069C5D-4FDC-444E-8C9B-20A60B05057A

P433

Q37578728-8BDD5BB4-EC5F-4E8A-B017-9A3D08636FE7

P478

Q37578728-76F26D01-386B-482F-A9BA-0243E11B61E3

P577

Q37578728-0E5774D2-8591-4224-9751-3A6F6785D7AF

P698

Q37578728-D0F355C8-5162-472F-9AC2-6618B172BE63

P921

Q37578728-083752EF-488A-480C-9488-E9B4DED9A51A

Q37578728-27879C6A-9525-48BC-AD1A-815319C5F868

Q37578728-2f396e78-3497-4a69-b5e9-aea737c24b6e

P932

Q37578728-A03EDDA8-4390-48DD-B9C9-5B88135614CE

P356

P1433

World Journal of Gastroenterology

P1476

Genetic and epigenetic biomark ...... treatment of colorectal cancer

@en

P2093

Angela Lopomo

http://www.w3.org/2001/XMLSchema#string

Fabio Coppedè

http://www.w3.org/2001/XMLSchema#string

Lucia Migliore

http://www.w3.org/2001/XMLSchema#string

Roberto Spisni

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

Epigenetics of colorectal cancer

CpG island methylator phenotype in colorectal cancer

Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

P304

943-956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I4.943

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24574767

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3921546

http://www.w3.org/2001/XMLSchema#string